Key insights
- Western Alliance Bancorp shares declined following the disclosure of a $99 million non-performing loan related to a life-science property. The bank is evaluating the financial impact, raising concerns about asset quality and potential losses. This news could negatively impact investor sentiment towards regional banks, particularly those with exposure to commercial real estate.
Investing.com -- Western Alliance Bancorp (NYSE:WAL) shares fell 5.9% to $77.10 on Monday after the regional lender disclosed a $99 million non-performing loan in its latest 10-Q filing.
The non-performing loan is tied to a life-science laboratory and office building, according to the filing.
Western Alliance Bancorp has ordered an appraisal and will conduct a valuation analysis to determine the financial impact.
As of Friday’s close, Western Alliance Bancorp stock was down 2.6% year-to-date.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.